Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 17, 2025Theoretical and Natural ScienceOpen Access

Mechanisms and Emerging Targeted Therapies of Uterine Serous Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

ZTZiqian Tian

Discussion

Loading...

Member takes

Overview

This overview discusses targeted therapies for uterine serous carcinoma, highlighting gene mutations and treatment implications.

Key Points

  • Targeted therapies may improve outcomes for patients with uterine serous carcinoma, reducing side effects.
  • Despite conventional treatments like surgery and chemotherapy, the recurrence rate of USC tumors remains high.
  • Emerging therapies include TP53-targeting drugs and HER-2-targeted therapies, offering new treatment avenues.
  • The need for targeted therapies arises from the limitations of traditional modalities in treating endometrial cancer.

Cite This Study

Ziqian Tian (2025) studied this question.

synapsesocial.com/papers/68d42c51713b0b5dfea6fa4bhttps://doi.org/10.54254/2753-8818/2025.au26856
View Full Paper
Ask AI
Bookmark
Share